PineBridge Investments’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,234
Closed -$12.9K 696
2023
Q2
$12.9K Hold
1,234
﹤0.01% 847
2023
Q1
$12.8K Hold
1,234
﹤0.01% 710
2022
Q4
$17K Hold
1,234
﹤0.01% 678
2022
Q3
$25K Hold
1,234
﹤0.01% 635
2022
Q2
$24K Buy
1,234
+1,034
+517% +$21.2K ﹤0.01% 643
2022
Q1
$4K Sell
200
-1,800
-90% -$40.8K ﹤0.01% 693
2021
Q4
$55K Buy
+2,000
New +$55.2K ﹤0.01% 698
2019
Q4
Sell
-3,452
Closed -$64K 1051
2019
Q3
$64K Buy
3,452
+1,316
+62% +$25.7K ﹤0.01% 1005
2019
Q2
$42K Buy
2,136
+152
+8% +$3.1K ﹤0.01% 943
2019
Q1
$45K Sell
1,984
-47,428
-96% -$1.03M ﹤0.01% 936
2018
Q4
$995K Sell
49,412
-2,325
-4% -$48.1K 0.02% 516
2018
Q3
$1.13M Sell
51,737
-24,235
-32% -$538K 0.02% 565
2018
Q2
$1.69M Sell
75,972
-13,826
-15% -$283K 0.04% 435
2018
Q1
$1.55M Buy
89,798
+19,510
+28% +$325K 0.04% 466
2017
Q4
$1.17M Buy
70,288
+18,504
+36% +$316K 0.03% 522
2017
Q3
$885K Buy
51,784
+337
+0.7% +$5.66K 0.02% 592
2017
Q2
$834K Sell
51,447
-206
-0.4% -$3.26K 0.02% 562
2017
Q1
$896K Buy
51,653
+17,072
+49% +$285K 0.02% 537
2016
Q4
$584K Buy
34,581
+30,923
+845% +$516K 0.02% 591
2016
Q3
$64K Buy
3,658
+546
+18% +$8.86K ﹤0.01% 912
2016
Q2
$45K Hold
3,112
﹤0.01% 971
2016
Q1
$38K Sell
3,112
-442
-12% -$4.88K ﹤0.01% 966
2015
Q4
$43K Buy
3,554
+278
+8% +$3.42K ﹤0.01% 965
2015
Q3
$43K Buy
3,276
+318
+11% +$4.8K ﹤0.01% 968
2015
Q2
$49K Sell
2,958
-3,336
-53% -$55.4K ﹤0.01% 951
2015
Q1
$112K Buy
6,294
+548
+10% +$10.2K ﹤0.01% 890
2014
Q4
$109K Buy
+5,746
New +$97.4K ﹤0.01% 896

Other funds holding ANGO

PineBridge Investments's ANGO Position: Q3 2023 in Review

PineBridge Investments sold out of AngioDynamics (ANGO) in Q3 2023, closing a stake of 1,234 shares — an estimated $12.9K sold.

PineBridge Investments first reported a position in ANGO in Q4 2014 and held it in 27 quarters. The position peaked at $1.69M in Q2 2018. 154 funds tracked by Wall St. Rank hold ANGO as of Q3 2023.

  • PineBridge Investments reported no remaining AngioDynamics position as of Q3 2023 after selling out during the quarter.
  • PineBridge Investments sold 1,234 AngioDynamics shares in Q3 2023, an estimated $12.9K.
  • PineBridge Investments first reported a position in AngioDynamics in Q4 2014 and held it in 27 quarters.
  • PineBridge Investments's AngioDynamics position peaked at $1.69M in Q2 2018.
  • 154 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2023.

Based on PineBridge Investments's 13F filing for Q3 2023, filed 14 Nov 2023.